• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FLEXIMA BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FLEXIMA BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00539210
Medical Device Problem Codes Positioning Failure (1158); Activation, Positioning or Separation Problem (2906)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/10/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Block h6: imdrf impact code f1001 is being used to capture the reportable event of aborted/cancelled procedure.
 
Event or Problem Description
Note: this report pertains to one of two devices used during the same procedure.Refer to manufacturer report # 3005099803-2024-03894 and 3005099803-2024-03895 for the associated device information.It was reported to boston scientific corporation that a flexima biliary preloaded stent was used in the bile duct for stricture management during an endoscopic retrograde cholangiopancreatography (ercp) procedure performed on (b)(6) 2024.During the procedure, the stent was unable to deploy as the suture was unable to be released.A second flexima biliary preloaded stent of a different size was used but the same problem occurred.The procedure was cancelled due to device availability.There were no patient complications reported as a result of this event.
 
Additional Manufacturer Narrative
Block h6: imdrf impact code f1001 is being used to capture the reportable event of aborted/cancelled procedure.Block h11: a flexima biliary stent and delivery system were received for analysis.Visual and media examination of the returned device found the guide catheter kinked, the push catheter suture hole torn, and the guide catheter cap detached.The suture didn't deploy the stent.No other problems were noted with the stent and delivery system.Product analysis confirmed the reported events of suture deployment issue and stent failure to deploy.The investigation concluded that the reported events and observed damages were likely caused by procedural difficulties encountered during the stent deployment process.If the stent was stuck unable to deploy and excessive pressure was applied during deployment, this could have damaged the push catheter suture hole by the pressure that the suture was adding to the suture hole.The same pressure may have contributed to the guide catheter becoming kinked and detached from the cap.Therefore, the most probable cause is adverse event related to procedure.A product labeling review identified that the device was used per the instructions for use (ifu) / product label.
 
Event or Problem Description
Note: this report pertains to one of two devices used during the same procedure.Refer to manufacturer report # 3005099803-2024-03894 and 3005099803-2024-03895 for the associated device information.It was reported to boston scientific corporation that a flexima biliary preloaded stent was used in the bile duct for stricture management during an endoscopic retrograde cholangiopancreatography (ercp) procedure performed on (b)(6) 2024.During the procedure, the stent was unable to deploy as the suture was unable to be released.A second flexima biliary preloaded stent of a different size was used but the same problem occurred.The procedure was cancelled due to device availability.There were no patient complications reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXIMA BILIARY
Common Device Name
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key19969006
Report Number3005099803-2024-03894
Device Sequence Number8832231
Product Code FGE
UDI-Device Identifier08714729162520
UDI-Public08714729162520
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K965147
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/15/2025
Device Model NumberM00539210
Device Catalogue Number3921
Device Lot Number0029057690
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/17/2024
Supplement Date Received by Manufacturer10/08/2024
Initial Report FDA Received Date08/12/2024
Supplement Report FDA Received Date11/01/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/16/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-